Takeda Faces First Trial Over Actos Diabetes Drug in L.A.

Takeda Pharmaceutical Co., Asia’s biggest drugmaker, is facing its first trial of lawsuits alleging that its Actos diabetes drug caused cancer in some patients.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.